7,590.00

+15.75

+0.21%

52,763.00

+265.00

+0.50%

28,010.75

-3.75

-0.01%

Russell 2000 Futures

2,859.50

+10.80

+0.38%

4.8640

+0.0050

+0.10%

19.73

-0.19

-0.95%

4,126.30

+11.80

+0.29%

74,332.10

+144.01

+0.19%

Crude Oil Dec 26

84.50

-2.35

-2.71%

US Private Equity

10,850.15

+77.38

+0.72%

Swiss - Delayed Quote CHF

Sandoz Group AG (SDZ.SW)

84.44 -0.02 (-0.02%)

As of 9:34:22 AM GMT+1. Market Open.

Loading Chart for SDZ.SW

Chart Range Bar

Interval:

In partnership with ChartIQ

A new Sandoz analysis reveals the next wave of affordable medicines is coming; will Canada be ready?

A new Sandoz analysis reveals the next wave of affordable medicines is coming; will Canada be ready?

Sandoz stock falls on sales outlook cut, Q3 miss

Sandoz stock falls on sales outlook cut, Q3 miss

‘Why do we value a Mars bar more than lifesaving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics

‘Why do we value a Mars bar more than lifesaving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics

Sandoz (SWX:SDZ) Stock Could Be 36% Undervalued On Cash Flow

Sandoz (SWX:SDZ) Stock Could Be 36% Undervalued On Cash Flow

Podcast: How Sandoz plans to harness its “golden decade”

Podcast: How Sandoz plans to harness its “golden decade”

Why Everyone Is Watching Sandoz Group (SWX:SDZ) Today

Why Everyone Is Watching Sandoz Group (SWX:SDZ) Today

Sandoz and mAbxience agree on emicizumab biosimilar partnership

Sandoz and mAbxience agree on emicizumab biosimilar partnership

Sandoz and mAbxience agree on emicizumab biosimilar partnership

Sandoz and mAbxience agree on emicizumab biosimilar partnership

“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy

“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy

Sandoz targets industry patent void with $322m Henlius deal

Sandoz targets industry patent void with $322m Henlius deal

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

Mobilize your Website

View Site in Mobile | Classic

Share by: